Lv3
300 积分 2021-08-09 加入
Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
14小时前
待确认
Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma
14小时前
待确认
Atezolizumab and bevacizumab for HCC in the real world
14小时前
已完结
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma
14小时前
已完结
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial
14小时前
已完结
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
15小时前
已完结
Immunotherapy in Anal Cancer
15小时前
待确认
Claudin 18.2 as a novel therapeutic target
15小时前
已完结
Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study
20天前
已关闭
Comparative Efficacy and Safety of Medical Treatments for the Management of Overactive Bladder: A Systematic Literature Review and Mixed Treatment Comparison
21天前
已完结
皖公网安备34019202002308
